GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes Mellitus.

Clin Ophthalmol · 2025 · PMC12535700 · PMID 41116973

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Over follow-up, patients treated with GLP-1 RAs showed a trend toward lower OSDI values compared with controls, although differences were not statistically significant at any timepoint ( Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.